News

Experimental Moderna flu shot more effective than approved vaccine, company says
Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...
Zacks Investment Research on MSN3h
Moderna Stock Gains on Encouraging Flu Vaccine Data
Moderna MRNA announced that its seasonal influenza vaccine candidate, mRNA-1010, achieved superior relative vaccine efficacy ...
New Scientist1d
Single antiviral shot could offer better protection than flu vaccines
A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...
Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine
RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...
Moderna says flu shot more effective than rival GSK in late-stage study
Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...
Medscape1d
High-Dose Flu Shot Beats Standard Dose in At-Risk Patients
Spanning nine influenza seasons, these studies enrolled 1862 patients, of whom 954 received the high-dose vaccine and 908 the standard-dose vaccine. Primary outcomes were immunogenicity (measured ...
Medical Dialogues3d
CDSCO Asks Serum Institute to Revise Protocol for Trivalent Flu-COVID Vaccine Trial
The Subject Expert Committee (SEC) under the COVID-19 division of the Central Drugs Standard Control Organization (CDSCO) has ...
Nature5d
RFK Jr’s vaccine advisers vote down flu-shot ingredient — but back some jabs
Thimerosal is found in only a small fraction of US vaccine doses but has long been viewed with suspicion by the ...